Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

UK: Pharmaceutical Press Publishes The Medicinal Uses of Cannabis and Cannabinoids

Business Wire

Friday 13 Aug 2004

---

CHICAGO--(BUSINESS WIRE)--Aug. 13, 2004--The Pharmaceutical Press, the
publications division of the Royal Pharmaceutical Society of Great Britain,
with offices in London and Chicago, has published the first edition of The
Medicinal Uses of Cannabis and Cannabinoids.

The publication is an authoritative review of the development of
cannabis-based medicines and their applications in a wide range of
therapeutic areas. It has been edited by Dr Geoffrey W Guy (Executive
Chairman, GW Pharmaceuticals), Dr Philip J Robson (Senior Research Fellow,
Department of Psychiatry, Oxford University and Medical Director, GW
Pharmaceuticals) and Dr Brian A Whittle (Scientific Director, GW
Pharmaceuticals).

The publication focuses on the research, development and clinical trial
results of the cannabis-based medicinal extract (CBME) Sativex for the
relief of chronic pain in MS sufferers, currently under review by the MHRA
for registration. It also covers a broad spectrum of subjects including the
history of cannabis use, its growth and morphology, the discovery and
pharmacology of cannabinoid receptors in mammalian tissues, the development
and use of synthetic cannabinoids, and the legal and forensic aspects of
cannabis within the international community.

Further chapters explore the research into the basic science of cannabis
and cannabinoids and highlight promising applications of CBMEs in the
treatment of epilepsy, schizophrenia, bladder dysfunction and as
broad-spectrum relief agents in patients with AIDS or cancer.

Professor Tony Moffat, the Society's Chief Scientist, said: "This
publication demonstrates the scientific credentials of cannabis and
cannabinoids as medicines. It is hoped that the evidence presented will
help to change the attitude of health professionals towards cannabis-based
medicines and enable the international legislative change required to allow
further collaborative research into prescription medicines."

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!